Management of Diuretic-Induced Hyponatremia

Immediate Management

The American College of Cardiology recommends holding all diuretics until sodium normalizes above 135 mEq/L in patients with diuretic-induced hyponatremia, as the patient has clear diuretic-induced hyponatremia from excessive self-administration 1, 2, 3
The American College of Cardiology suggests continuing fluid restriction and high-protein diet as first-line interventions for hypervolemic hyponatremia in heart failure patients 1, 2
Monitoring sodium every 24-48 hours until stable and normalized is recommended, which aligns with the current BMP monitoring schedule 3
Patients who are not volume overloaded on exam do not require aggressive diuresis, as indicated by the absence of pulmonary edema on CXR, normal oxygen saturation, and diminished but not congested breath sounds 1, 2

With CKD stage 3b, loop diuretics like furosemide remain effective, but thiazide-type diuretics lose effectiveness at creatinine clearance <40 mL/min and increase the risk of electrolyte abnormalities 3
Metolazone should be permanently discontinued in patients with CKD stage 3b due to its ineffectiveness and increased risk of electrolyte abnormalities 3
The combination of loop diuretic plus metolazone markedly enhances the risk of electrolyte depletion, which can occur in patients with CKD stage 3b 4

The American College of Cardiology recommends continuing current heart failure medications, such as sacubitril-valsartan and apixaban, in patients who are hemodynamically stable, with a blood pressure range of 115-130/61-78 mmHg 1, 2
Entresto should not be held unless the patient becomes hypotensive or develops acute kidney injury 1, 2

The American College of Cardiology states that vasopressin antagonists are not indicated for asymptomatic patients with improving sodium on conservative management, and are only considered for persistent severe hyponatremia with cognitive symptoms despite water restriction 1, 2, 5
Vasopressin antagonists did not improve mortality in heart failure patients and have unknown long-term safety, according to the American College of Cardiology 1, 2, 5

The American College of Cardiology recommends checking BMP every 24-48 hours until sodium >135 mEq/L, and monitoring electrolytes and renal function every 3-6 months once stable 3
Consideration of nephrology consultation is recommended if sodium fails to improve or if complex diuretic management is needed given the patient's CKD stage 3b 3